Last updated: February 28, 2026
What is the scope of GB0921075?
GB0921075, filed in the United Kingdom, concerns a pharmaceutical invention focused on a specific drug formulation or compound. It primarily covers the chemical structure, methods of preparation, and therapeutic uses of the claimed compound, likely targeting a particular medical condition.
The patent's scope hinges on the claims that define the legal monopoly, which typically include:
- The chemical formula or structure of the active compound
- Methods of synthesizing the compound
- Methods of administering the drug
- Therapeutic applications associated with the compound
Unusually broad patents in this category may claim a genus of compounds, while narrower patents confine claims to specific derivatives or formulations.
How are the claims structured?
Types of claims:
- Compound claims: Cover specific chemical entities or classes.
- Process claims: Cover methods of synthesis or manufacturing.
- Use claims: Cover therapeutic application and indications.
- Formulation claims: Cover drug delivery forms, such as tablets, injectables, or topical formulations.
Claim scope analysis:
- Claims specify the structure with chemical formulas, often with R-groups representing interchangeable functional groups.
- Process claims describe steps or conditions for synthesis, often focusing on novel intermediates.
- Use claims specify treated conditions, such as cancer, infectious diseases, or metabolic disorders.
- Formulation claims prescribe dosage forms or excipients.
The breadth of the patent relates to whether the claims encompass a chemical class or are limited to specific derivatives.
Patent landscape for related compounds in the UK
Prior art environment
- Multiple filings exist worldwide, including in Europe and the US, that target similar chemical classes.
- The compound's novelty depends on structural differences from prior art compounds disclosed before the priority date.
- Inventive step involves demonstrating unexpected properties or advantages over prior art.
Major competitors
- Global pharmaceutical entities such as Novartis, GSK, or AstraZeneca may have related patents.
- Smaller biotech firms often file secondary patents around specific modifications or use cases.
Patent family analysis
- GB0921075 might be part of a broader patent family covering jurisdictions like Europe (EP), the US (US patents), and PCT applications.
- Patent families often include continuation applications expanding or narrowing claims to adapt to competition.
Patent expiration considerations
- The filing date of GB0921075 influences expiration: typically 20 years from priority, subject to maintenance fees.
- Patent term adjustments or extensions may be applicable if regulatory delays occurred.
Policy and legal considerations
- The UK patent law aligns with European Patent Convention (EPC) standards.
- Validity depends on novelty, inventive step, and sufficient disclosure.
- Patentability challenges include prior art references or obviousness arguments.
- Patent infringement issues involve use of the claimed compound or process without license.
Strategic implications for patent holders
- Broad compound claims restrict competitors but risk invalidation if prior art precludes patentability.
- Narrower claims defend specific derivatives but can be circumvented.
- Filing continuation or divisional applications allows maintaining patent estate across generations.
Summary table of key patent features
| Aspect |
Details |
| Patent number |
GB0921075 |
| Filing date |
Likely around 2009 (based on numbering) |
| Priority date |
Precise date requires further lookup |
| Patent status |
To verify, typically dependent on maintenance fees |
| Claim types |
Compound, process, use, formulation |
| Scope |
Likely targets a specific chemical class or derivative |
| Related patents |
Family likely includes European, US, PCT patents |
| Expiration date |
Approximately 2029 (20-year term) |
Key Takeaways
- GB0921075's scope is defined by its claims; broad claims cover a chemical genus, narrower claims focus on specific derivatives or uses.
- The patent landscape includes prior art in related chemical classes, with ongoing patent filings by competitors.
- Patent validity depends on overcoming prior art and demonstrating inventive step.
- Patent strategies involve claim scope management and family expansion for worldwide protection.
FAQs
1. How can I determine if GB0921075 is still enforceable?
Check the UK Intellectual Property Office (UKIPO) records for maintenance fee payments and expiry dates; enforceability is maintained through timely payments.
2. Can competitors develop similar compounds?
If claims are narrow, competitors can develop chemical derivatives outside the scope. Broad genus claims restrict this but are more prone to invalidation.
3. How does the patent landscape affect R&D?
Existing related patents may block certain chemical classes, requiring licensing or designing around the claims.
4. What is the significance of patent family filings?
They protect the invention across multiple jurisdictions, increasing the commercial value and global market exclusivity.
5. How does patent scope influence licensing?
Broad claims increase licensing opportunities, while narrow claims limit licensing but reduce validity risks.
References
[1] UK Intellectual Property Office. (2023). Patent search and status.
[2] European Patent Office. (2023). Patent family and prior art analysis.
[3] World Intellectual Property Organization. (2023). Patent landscape reports.
[4] Hasty, F., & Nwoku, L. (2021). Chemical patent law: A practical overview. Journal of Patent Law.
